Deficiency of BLOS1 moderately impairs the biogenesis of platelet dense granules

Yefeng Yuan1,2,3,4,5, Wei Li1,2,3,4

  • 1Laboratory for Genetics of Birth Defects, Beijing Pediatric Research Institute, Beijing, China.

Platelets
|August 19, 2025
PubMed

Insights

Defects in platelet dense granule (DG) biogenesis cause bleeding disorders. This study shows BLOS1 deficiency moderately impairs DG formation, unlike dysbindin deficiency, revealing distinct roles in platelet function.

Area of Science:

  • Hematology
  • Cell Biology
  • Genetics

Background:

  • Platelet secretion defects are linked to hemorrhagic disorders and coagulopathies.
  • Lysosome-related organelles (LROs), including alpha granules (AGs) and dense granules (DGs), are crucial for platelet function.
  • Lysosome-related organelles complex-1 (BLOC-1) deficiencies impair DG formation, but individual subunit roles are unclear.

Purpose of the Study:

  • To investigate the role of BLOS1, a subunit of BLOC-1 and BLOC-1-related complex (BORC), in LRO biogenesis and platelet function.
  • To compare the effects of BLOS1 deficiency with dysbindin (a BLOC-1 subunit) deficiency on DG formation and secretion.

Main Methods:

  • Comparative analysis of platelet-specific *Bloc1s1*-conditional knockout (*Bloc1s1-cKO*) mice and *sdy* mice (dysbindin deficient).
  • Quantification of DG content in platelets.
  • Assessment of agonist-induced DG secretion.
  • Analysis of steady-state levels of granule proteins.

Main Results:

  • *Bloc1s1-cKO* platelets showed a 50% reduction in DG content compared to *sdy* mice.
  • Agonist-induced DG secretion was moderately impaired in *Bloc1s1-cKO* mice, contrasting with severe defects in *sdy* mice.
  • Distinct steady-state levels of granule proteins were observed between the two mutant models.

Conclusions:

  • BLOS1 deficiency causes moderate defects in dense granule biogenesis and secretion.
  • Dysbindin and BLOS1 play distinct roles in regulating lysosome-related organelle biogenesis and function.
  • Understanding these distinct roles is critical for addressing platelet secretion disorders.

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.5K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
7.1K
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K